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Abstract The oncogenic transcription factor Myc is one
of the most interesting members of the basic-helix-loop-
helix-zipper (bHLHZip) protein family. Deregulation of
Myc via gene amplification, chromosomal translocation
or other mechanisms lead to tumorigenesis including
Burkitt lymphoma, multiple myeloma, and many other
malignancies. The oncogene myc is a highly potent trans-
forming gene and capable to transform various cell types
in vivo and in vitro. Its oncogenic activity initialized by
deregulated expression leads to a shift of the equilibrium in
the Myc/Max/Mad network towards Myc/Max complexes.
The Myc/Max heterodimerization is a prerequisite for
transcriptional functionality of Myc. Primarily, we are
focusing on the apo-state of the C-terminal domain of
v-Myc, the retroviral homolog of human c-Myc. Based on
multi-dimensional NMR measurements v-Myc appears to
be neither a fully structured nor a completely unstructured
protein. The bHLHZip domain of v-Myc does not exist as a
random coil but exhibits partially pre-formed a-helical
regions in its apo-state. In order to elucidate the structural
propensities of Myc in more detail, the backbone and side-
chain assignments obtained here for apo-Myc are a crucial
prerequisite for further NMR measurements.
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Biological context
The v-myc oncogene encoding the v-Myc protein is the
transforming principle of avian Myelocytomatosis virus
MC29 (Bister and Jansen 1986), an acute leukemia virus
isolated from a chicken tumor (Ivanov et al. 1964). The
viral genome encodes the transforming protein in form of a
Gag-Myc hybrid protein encompassing 450 N-terminal
residues encoded by the 50 end of gag, linked to nine res-
idues encoded by sequences derived from noncoding
regions of c-myc (cellular myc), followed by 416 residues
encoded by sequences derived from the protein coding
regions of exons 2 and 3 of c-myc (Reddy et al. 1983;
Bister and Jansen 1986). The v-Myc amino acid sequence
differs from that of c-Myc by only a few amino acid sub-
stitutions. There are multiple mechanisms to drive c-myc
into deregulated expression such as retroviral transduction,
viral integration, chromosomal translocation, and gene
amplification. Alteration of human c-myc via chromosomal
translocation was found in Burkitt lymphoma (Dalla-
Favera et al. 1982). Translocation of c-myc is also fre-
quently seen in multiple myeloma cases (Shou et al. 2000).
An enhanced TCF transcriptional activation of c-myc can
be induced by defects in the Wnt-APC pathway (He
et al. 1998). The transduced v-myc allele is one of the
most potent transforming genes (Bister and Jansen 1986;
Frykberg et al. 1987). It is capable to transform several
different lineages of mammalian and avian cells. The most
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prominent fate for a cell after transformation by v-myc is
enhanced proliferation. A v-myc transformed cell can
become growth factor independent and as a consequence
can develop an immortal and tumorigenic phenotype.
Myc’s importance and power over the fate of cells
derives from the fact that Myc is a transcription factor.
Together with its C-terminal binding partner Max (Myc
associated factor X) it binds as a heterodimer to its cognate
E-box DNA sequence (50-CACGTG-30) found frequently
throughout the genome. A large number of target genes
have been found. Currently the Myc database (myccan-
cergene.org) lists more than 1,600 target genes. The Myc
target genes are involved in many different functional
processes including cell cycle control, cell growth, metab-
olism, apoptosis and immortality. The bHLHZip domain of
Myc is essential for binding to Max and ranges from residue
314 to 416 of full-length v-Myc. Structural preformation of
Myc in the apo-state (prior to Max binding) has already
been shown via multi-dimensional NMR (Fieber et al.
2001). The partially folded monomeric Myc showed
dynamic features such as helical fraying and a directed
flexibility in the loop region.
Myc is thus another example for the growing evidence
that binding interactions with intrinsically disordered
proteins (IDP) largely proceed via conformational selec-
tion from a significantly narrowed conformation ensem-
ble. In order to properly characterize the preformed
structural ensemble of Myc, a complete signal assignment
including side-chains is indispensible. Severe spectral
overlaps make complete signal assignment a challenging
task in IDPs.
Lavigne et al. provided 1998 a solution structure of
N-terminal disulfide-linked versions of the c-Myc-Max
heterodimeric Leucine Zipper solved by 2D H-NMR. A
full backbone assignment of v-Myc in complex with its
binding partner Max was published by Baminger et al. in
2004. Here we provide a complete signal assignment,
backbone and side-chain, for the bHLHZip domain of apo
(monomeric) v-Myc, using a set of high-dimensional triple
resonance NMR experiments. Apo v-Myc shows a different
spectra in respect to the heterodimeric Myc-Max complex.
For more details compare with BMRB entry 6163. Our data
will not only be crucial for the characterization of Myc’s
apo-state, but also a valuable source of information for the
analysis of amino-acid side chains in IDPs.
Methods and results
Expression and purification of v-Myc
The v-Myc bHLHZip domain encoding fragment was
obtained by cleavage of the pET3dmycmax expression
plasmid (Fieber et al. 2001; Baminger et al. 2004) using
BamH1 and NcoI. The resulting fragment was ligated into
the pETM-11 expression vector providing v-Myc with a
N-terminal His-tag. The pETM-11v-myc plasmid was
transformed into Rosetta(DE3)pLysS cells for protein
expression following a protocol for efficient isotopic
labeling of recombinant proteins using a fourfold cell
concentration in minimal medium containing 15NH4Cl and
13C-glucose (Marley et al. 2001). v-Myc was expressed in
inclusion bodies. The cells were collected after overnight
expression at 30 C by centrifugation at 4,000 rpm for
15 min and resuspended in 30 ml of ice-cold lysis buffer
(20 mM NaH2PO4/Na2HPO4, 100 mM NaCl, 1 mM
EDTA, 1 mM DTT, pH 6.5). The cells were lysed via
sonication at 70 % for 3 9 5 min. After cell lysis, the
lysate was cleared by centrifugation at 18,000 rpm for
20 min. The pellet was resuspended in 8 M Urea
(including 1 mM EDTA, 100 mM NaCl and 20 mM
imidazole, pH 8) and loaded onto a Ni2?-loaded HisTrap
FF 5 ml affinity column (GE Healthcare) and eluted with
8 M Urea containing 100 mM imidazole. The eluate was
collected and a step-wise refolding in 4 steps with buffer
(20 mM NaH2PO4/Na2HPO4, 100 mM NaCl, 1 mM
EDTA, 1 mM DTT, pH 6.5) was performed at 4 C. After
refolding the sample was concentrated to approximately
0.7 mM.
NMR experiments
All spectra were acquired at 298 K on an Agilent Direct
Drive 700 MHz spectrometer using a standard 5 mm
1H–13C–15N triple-resonance probehead.
The backbone 1H, 13C, and 15N resonances were
assigned using sparse random sampling of indirectly
detected time domains, in order to increase resolution. A 3D
HNCO experiment was used as a base spectrum for SMFT
(Sparse Multidimensional Fourier Transform) processing of
higher dimensionality experiments (Kazimierczuk et al.
2010). Backbone assignment was achieved using 5D
HN(CA)CONH (Kazimierczuk et al. 2010), (HACA)-
CON(CA)CONH, (H)NCO(NCA)CONH and HNCO-
CACB (Zawadzka-Kazimierczuk et al. 2012b) experiments.
Side-chain assignments were obtained using 5D HabCab-
CONH (Kazimierczuk et al. 2010), and H(CC-tocsy)CONH
(Kazimierczuk et al. 2009) experiments.
All NMR data sets were processed by multidimensional
Fourier transformation using the home written software
package (http://nmr700.chem.uw.edu.pl). The resonance
assignment was performed using the TSAR program
(Zawadzka-Kazimierczuk et al. 2012a). The input data for
TSAR was prepared using Sparky software (Goddard and
Kneller 2002).
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Fig. 1 2D 15N-HSQC spectrum with a zoom of the central crowded region of his-tagged v-Myc at pH 6.5 and 25 C. Assignments of backbone
amides are indicated with the one-letter code for amino acids and the residue numbers (his-tag:1-27, v-Myc:314-416)
a
b
Fig. 2 2D spectral planes for v-Myc obtained by SMFT procedure performed on the 5D randomly sampled signal (Poisson disk sampling).
a (HACA)CON(CA)CONH and b HN(CA)CONH
1H, 13C, and 15N backbone 323
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Extent of assignment and data deposition
The 1H–15N HSQC spectrum of v-Myc shows a very nar-
row peak dispersion in the 1H dimension typical for
intrinsically disordered proteins (Fig. 1). Extensive signal
overlap in conventional 2D and 3D spectra could be
overcome by using the aforementioned 5D experiments.
97.1 % of backbone 15N, 96 % of 1HN, 91.3 % of 13Ca,
90.4 % of 1Ha, 91.3 % of 13Cb, 90.4 % of 1Hb and 95.2 %
of 13C0 resonances have been assigned (calculated without His-
tag). Figure 2 shows sample strips of sequential resonance
assignment in a 5D (HACA)CON(CA)CONH and HN(CA)
CONH experiment. Additionally, H(CC-tocsy)CONH spectra
allowed the assignment of several side-chain atoms. 43 % of
Cc (calculated without His), 50 % of Hc, 32 % of Cd, and
42.1 % of Hd could be assigned.
The assignments have been deposited in the BioMa-
gResBank database (http://www.bmrb.wisc.edu) under
accession number: 18580.
Acknowledgments NMR experiments were carried out in the
Structural Research Laboratory at the Faculty of Chemistry, Univer-
sity of Warsaw. This work was supported by the EAST-NMR project
(contract no. 228461) inside of a transnational access program (pro-
posal acronym: HISMYC). S. S., S. _Z, and W. K. thank the Foun-
dation for Polish Science for support with the TEAM Programme.
The TEAM programme is co-financed by the EU European Regional
Development. We also thank the Austrian Science Fund (FWF):
W1221-B03.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
References
Baminger B, Ludwiczel ML, Hoffmann B, Kontaxis G, Bister K,
Konrat R (2004) Backbone assignment of the dimerization and
DNA-binding domain of the oncogenic transcription factor
v-Myc in complex with its authentic binding partner Max.
J Biomol NMR 30:361–362
Bister K, Jansen HW (1986) Oncogenes in retroviruses and cells:
biochemistry and molecular genetics. Adv Cancer Res 47:
99–188
Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RC, Croce
CM (1982) Human c-myc onc gene is located on the region of
chromosome 8 taht is translocated in Burkitt lymphoma cells.
Proc Natl Acad Sci USA 79:7824–7827
Fieber W, Schneider ML, Matt T, Kra¨utler B, Konrat R, Bister K
(2001) Structure, function, and dynamics of the dimerization and
DNA-binding domain of oncogenic transcription factor v-Myc.
J Mol Biol 307:1395–1410
Frykberg L, Graf T, Vennstrom B (1987) The transforming activity of
the chicken c-myc gene can be potentiated by mutations.
Oncogene 1(4):415–422
Goddard TD, Kneller DG (2002) Sparky 3. University of California,
San Francisco
He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT,
Morin PJ, Vogelstein B, Kinzler KW (1998) Identification of
c-Myc as a target of the APC pathway. Science 281:1509–1512
Ivanov X, Mladenov Z, Nedyalkov S, Todorov TG, Yakimov M
(1964) Experimental investigations into avian leucoses. V. Trans-
mission, haematology and morphology of avian myelocytoma-
tosis. Bull Inst Pathol Comp Anim 10:5–38
Kazimierczuk K, Zawadzka A, Kozminski W (2009) Narrow peaks
and high dimensionalities: exploiting the advantages of random
sampling. J Magn Reson 197:219–228
Kazimierczuk K, Zawadzka-Kazimierczuk A, Kozminski W (2010)
Non-uniform frequency domain for optimal exploitation of non-
uniform sampling. J Magn Reson 205:286–292
Lavigne P, Crump MP, Gagne SM, Hodges RS, Kay CM, Sykes BD
(1998) Insights into the mechanism of heterodimerization from
the 1H-NMR solution structure of the c-Myc-Max heterodimeric
leucine zipper. J Mol Biol 281:165–181
Marley J, Lu M, Bracken C (2001) A method for efficient isotopic
labelling of recombinant proteins. J Biomol NMR 20:71–75
Reddy RK, Watson DK, Schultz RA, Lautenberger J, Papas TS
(1983) Nucleotide sequence analysis of the proviral genome of
avian myelocytomatosis virus (MC29). Proc Natl Acad Sci USA
80(9):2500–2504
Shou Y, Martelli ML, Gabrea A, Qi Y, Brents LA, Roschke A,
Dewald G, Kirsch IR, Bergsagel PR, Kuehl WM (2000) Diverse
karyotypic abnormalities of the c-myc locus associated with
c-myc dysregulation and tumor progression in multiple mye-
loma. Proc Natl Acad Sci USA 97:228–233
Zawadzka-Kazimierczuk A, Kozminski W, Billeter M (2012a) TSAR
a program for automatic resonance assignment using cross-
sections of high dimensionality, high-resolution spectra. J Biomol
NMR 54:81–95 doi:10.1007/s10858-012-9652-3
Zawadzka-Kazimierczuk A, Kozminski W, Sanderova H, Krasny L
(2012b) High dimensional and high resolution pulse sequences
for backbone resonance assignment of intrinsically disordered
proteins. J Biomol NMR 52:329–337
324 G. Kızılsavas¸ et al.
123
